
Ralph J. Gitomer
Examiner (ID: 10080, Phone: (571)272-0916 , Office: P/1657 )
| Most Active Art Unit | 1657 |
| Art Unit(s) | 1803, 2899, 1651, 1657, 1815, 1655, 1627, 1623, 1622, 1211 |
| Total Applications | 3335 |
| Issued Applications | 2109 |
| Pending Applications | 286 |
| Abandoned Applications | 943 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5880914
[patent_doc_number] => 20060029997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'CLONING AND EXPRESSION OF RECOMBINANT ADHESIVE PROTEIN MEFP-1 OF THE BLUE MUSSEL, MYTILUS EDULIS'
[patent_app_type] => utility
[patent_app_number] => 10/915161
[patent_app_country] => US
[patent_app_date] => 2004-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7522
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029997.pdf
[firstpage_image] =>[orig_patent_app_number] => 10915161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/915161 | Cloning and expression of recombinant adhesive protein Mefp-1 of the blue mussel, Mytilus edulis | Aug 8, 2004 | Issued |
Array
(
[id] => 5880913
[patent_doc_number] => 20060029996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'CLONING AND EXPRESSION OF RECOMBINANT ADHESIVE PROTEIN MEFP-2 OF THE BLUE MUSSEL, MYTILUS EDULIS'
[patent_app_type] => utility
[patent_app_number] => 10/915160
[patent_app_country] => US
[patent_app_date] => 2004-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7666
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10915160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/915160 | Cloning and expression of recombinant adhesive protein MEFP-2 of the blue mussel, Mytilus edulis | Aug 8, 2004 | Issued |
Array
(
[id] => 7084020
[patent_doc_number] => 20050049400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Method and system for extraction of zein and/or oil from corn'
[patent_app_type] => utility
[patent_app_number] => 10/913790
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5039
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049400.pdf
[firstpage_image] =>[orig_patent_app_number] => 10913790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/913790 | Method and system for extraction of zein from corn | Aug 5, 2004 | Issued |
Array
(
[id] => 641654
[patent_doc_number] => 07122353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Targeted carrier fusions for delivery of chemotherapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 10/912764
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 32191
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122353.pdf
[firstpage_image] =>[orig_patent_app_number] => 10912764
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/912764 | Targeted carrier fusions for delivery of chemotherapeutic agents | Aug 4, 2004 | Issued |
Array
(
[id] => 5075180
[patent_doc_number] => 20070015155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Novel protein usable in screening drug improving type 2 diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/547365
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17667
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015155.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547365
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547365 | Novel protein usable in screening drug improving type 2 diabetes | Aug 4, 2004 | Abandoned |
Array
(
[id] => 380198
[patent_doc_number] => 07309773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-18
[patent_title] => 'Process for preparation of flax protein isolate'
[patent_app_type] => utility
[patent_app_number] => 10/902102
[patent_app_country] => US
[patent_app_date] => 2004-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8953
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/309/07309773.pdf
[firstpage_image] =>[orig_patent_app_number] => 10902102
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/902102 | Process for preparation of flax protein isolate | Jul 29, 2004 | Issued |
Array
(
[id] => 7026434
[patent_doc_number] => 20050020491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Decorin proteoglycan inhibitor of fibrinogen blood clotting'
[patent_app_type] => utility
[patent_app_number] => 10/898841
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4187
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020491.pdf
[firstpage_image] =>[orig_patent_app_number] => 10898841
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/898841 | Decorin proteoglycan inhibitor of fibrinogen blood clotting | Jul 25, 2004 | Issued |
Array
(
[id] => 860660
[patent_doc_number] => 07371820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-13
[patent_title] => 'Nutraceuticals for the treatment, protection and restoration of connective tissues'
[patent_app_type] => utility
[patent_app_number] => 10/896546
[patent_app_country] => US
[patent_app_date] => 2004-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 21534
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/371/07371820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10896546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/896546 | Nutraceuticals for the treatment, protection and restoration of connective tissues | Jul 21, 2004 | Issued |
Array
(
[id] => 6912263
[patent_doc_number] => 20050176021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Human RalGDS-like protein 3'
[patent_app_type] => utility
[patent_app_number] => 10/894680
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 38053
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10894680
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/894680 | Human RalGDS-like protein 3 | Jul 18, 2004 | Abandoned |
Array
(
[id] => 6997354
[patent_doc_number] => 20050137132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Uses of novel potassium channel blockers'
[patent_app_type] => utility
[patent_app_number] => 10/892499
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10447
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137132.pdf
[firstpage_image] =>[orig_patent_app_number] => 10892499
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/892499 | Uses of novel potassium channel blockers | Jul 15, 2004 | Abandoned |
Array
(
[id] => 463012
[patent_doc_number] => 07238497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors'
[patent_app_type] => utility
[patent_app_number] => 10/891302
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 18
[patent_no_of_words] => 7086
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/238/07238497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10891302
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891302 | Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors | Jul 13, 2004 | Issued |
Array
(
[id] => 7203225
[patent_doc_number] => 20050042725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression system and biosensors'
[patent_app_type] => utility
[patent_app_number] => 10/891333
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7054
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042725.pdf
[firstpage_image] =>[orig_patent_app_number] => 10891333
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891333 | Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors | Jul 13, 2004 | Issued |
Array
(
[id] => 428683
[patent_doc_number] => 07268117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-11
[patent_title] => 'Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis'
[patent_app_type] => utility
[patent_app_number] => 10/887775
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23003
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/268/07268117.pdf
[firstpage_image] =>[orig_patent_app_number] => 10887775
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/887775 | Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis | Jul 8, 2004 | Issued |
Array
(
[id] => 6972253
[patent_doc_number] => 20050037963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Methods of regulating focal adhesion kinase and its associated cellular functions by fak family-interacting protein'
[patent_app_type] => utility
[patent_app_number] => 10/886744
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23859
[patent_no_of_claims] => 97
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037963.pdf
[firstpage_image] =>[orig_patent_app_number] => 10886744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/886744 | Methods of regulating focal adhesion kinase and its associated cellular functions by fak family-interacting protein | Jul 7, 2004 | Abandoned |
Array
(
[id] => 773210
[patent_doc_number] => 07001744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-21
[patent_title] => 'Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection'
[patent_app_type] => utility
[patent_app_number] => 10/877670
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10988
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877670 | Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection | Jun 24, 2004 | Issued |
Array
(
[id] => 7061124
[patent_doc_number] => 20050003485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Method for recombinant production of polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/866567
[patent_app_country] => US
[patent_app_date] => 2004-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3430
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003485.pdf
[firstpage_image] =>[orig_patent_app_number] => 10866567
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/866567 | Method for recombinant production of polypeptides | Jun 11, 2004 | Issued |
Array
(
[id] => 645640
[patent_doc_number] => 07119168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-10
[patent_title] => 'Paralytic peptide for use in neuromuscular therapy'
[patent_app_type] => utility
[patent_app_number] => 10/858233
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 11656
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/119/07119168.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858233
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858233 | Paralytic peptide for use in neuromuscular therapy | May 31, 2004 | Issued |
Array
(
[id] => 7252476
[patent_doc_number] => 20040259221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Separation of cytosolic and nuclear proteins'
[patent_app_type] => new
[patent_app_number] => 10/850734
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3371
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259221.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850734
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850734 | Separation of cytosolic and nuclear proteins | May 20, 2004 | Abandoned |
Array
(
[id] => 941311
[patent_doc_number] => 06969702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-29
[patent_title] => 'Compounds and methods for increasing neurogenesis'
[patent_app_type] => utility
[patent_app_number] => 10/850055
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23893
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/969/06969702.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850055
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850055 | Compounds and methods for increasing neurogenesis | May 18, 2004 | Issued |
Array
(
[id] => 7252853
[patent_doc_number] => 20050142641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Group I mite polypeptide variants'
[patent_app_type] => utility
[patent_app_number] => 10/831027
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 30181
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142641.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831027
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831027 | Group I mite polypeptide variants | Apr 22, 2004 | Abandoned |